D. Serin
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Bone health and treatments
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 39
- Cancer Treatment and Pharmacology 24
- Cancer survivorship and care 6
- HER2/EGFR in Cancer Research 5
-
- Breast Cancer Treatment Studies 27
- Co-authors
- P. Fumoleau (5 shared papers)M. Namer (12 shared papers)R. Largillier (3 shared papers)B. Audhuy (5 shared papers)Jean‐François Morère (4 shared papers)Hubert Orfeuvre (3 shared papers)E. Vuillemin (2 shared papers)H. Curé (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)European Journal of Cancer (8 papers)Cancer Research (5 papers)Annals of Oncology (4 papers)British Journal of Cancer (2 papers)
- Partner nations
- FranceBelgiumUnited Kingdom
In The Last Decade
D. Serin
69 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 70
- Oncology 617
- Cancer Research 294
- Genetics 354
- Dermatology 102
- Public Health, Environmental and Occupational Health 181
Countries citing papers authored by D. Serin
This map shows the geographic impact of D. Serin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Serin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Serin more than expected).
Fields of papers citing papers by D. Serin
This network shows the impact of papers produced by D. Serin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Serin. The network helps show where D. Serin may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Serin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 252 | |
| 2 | 2009 | 131 | |
| 3 | 1997 | 123 | |
| 4 | 1996 | 94 | |
| 5 | 2003 | 90 | |
| 6 | 2006 | 53 | |
| 7 | 1999 | 41 | |
| 8 | Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer. | 1995 | 41 |
| 9 | 1996 | 32 | |
| 10 | 2006 | 31 | |
| 11 | [Frequency of lymphedema of the upper limb after treatment of breast cancer. Risk factors. Apropos of 683 cases]. | 1996 | 26 |
| 12 | 2007 | 24 | |
| 13 | [Lymphoscintigraphic aspects of the effects of manual lymphatic drainage]. | 1996 | 24 |
| 14 | 1993 | 16 | |
| 15 | 2002 | 14 | |
| 16 | 2004 | 14 | |
| 17 | 2012 | 13 | |
| 18 | 1982 | 12 | |
| 19 | 2005 | 12 | |
| 20 | 2007 | 11 |
About D. Serin
D. Serin is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and General Health Professions, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (27 papers), Cancer Treatment and Pharmacology (24 papers), Advanced Breast Cancer Therapies (10 papers), Estrogen and related hormone effects (6 papers), Cancer survivorship and care (6 papers), HER2/EGFR in Cancer Research (5 papers), Chemotherapy-related skin toxicity (5 papers) and BRCA gene mutations in cancer (5 papers). The work is most often cited by research in Oncology (617 citations), Cancer Research (294 citations), Genetics (354 citations), Dermatology (102 citations) and Public Health, Environmental and Occupational Health (181 citations). D. Serin has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include P. Fumoleau, M. Namer, R. Largillier, B. Audhuy, Jean‐François Morère, Hubert Orfeuvre, E. Vuillemin, H. Curé, Stéphane Culine and Thierry Lesimple. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Cancer Research, Annals of Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.